• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Esophagitis: a novel adverse event of crizotinib in a patient with ALK-positive non-small-cell lung cancer.

作者信息

Srivastava Neeharika, VanderLaan Paul A, Kelly Ciaran P, Costa Daniel B

机构信息

Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

出版信息

J Thorac Oncol. 2013 Mar;8(3):e23-4. doi: 10.1097/JTO.0b013e31827e2451.

DOI:10.1097/JTO.0b013e31827e2451
PMID:23407563
Abstract
摘要

相似文献

1
Esophagitis: a novel adverse event of crizotinib in a patient with ALK-positive non-small-cell lung cancer.食管炎：克唑替尼在一名ALK阳性非小细胞肺癌患者中引起的一种新的不良事件。
J Thorac Oncol. 2013 Mar;8(3):e23-4. doi: 10.1097/JTO.0b013e31827e2451.
2
Crizotinib: a new treatment option for ALK-positive non-small cell lung cancer.克唑替尼：ALK 阳性非小细胞肺癌的新治疗选择。
Ann Pharmacother. 2013 Feb;47(2):189-97. doi: 10.1345/aph.1R002. Epub 2013 Feb 5.
3
Crizotinib-induced pancreatic pseudocyst: a novel adverse event.克唑替尼诱发的胰腺假性囊肿：一种新的不良事件。
BMJ Case Rep. 2015 Sep 8;2015:bcr2015211556. doi: 10.1136/bcr-2015-211556.
4
Crizotinib-induced acute interstitial lung disease in a patient with EML4-ALK positive non-small cell lung cancer and chronic interstitial pneumonia.克唑替尼诱发的急性间质性肺病，发生在一名EML4-ALK阳性非小细胞肺癌合并慢性间质性肺炎的患者身上。
Acta Oncol. 2014 Jan;53(1):158-60. doi: 10.3109/0284186X.2013.802838. Epub 2013 Jun 11.
5
Crizotinib-induced cardiotoxicity: the importance of a proactive monitoring and management.克唑替尼引起的心脏毒性：积极监测与管理的重要性
Future Oncol. 2015;11(14):2043-8. doi: 10.2217/fon.15.47.
6
A safety assessment of crizotinib in the treatment of ALK-positive NSCLC patients.克唑替尼治疗ALK阳性非小细胞肺癌患者的安全性评估。
Expert Opin Drug Saf. 2015 Mar;14(3):485-93. doi: 10.1517/14740338.2015.1007040. Epub 2015 Feb 7.
7
Xanthogranulomatous pyelonephritis complicating crizotinib treatment of an ALK-rearranged non-small-cell lung cancer.克唑替尼治疗ALK重排非小细胞肺癌并发黄色肉芽肿性肾盂肾炎
Diagn Interv Imaging. 2018 Apr;99(4):267-268. doi: 10.1016/j.diii.2018.01.008. Epub 2018 Feb 19.
8
Variants on a theme: a biomarker of crizotinib response in ALK-positive non-small cell lung cancer?万变不离其宗：ALK 阳性非小细胞肺癌中克唑替尼反应的生物标志物？
Clin Cancer Res. 2012 Sep 1;18(17):4479-81. doi: 10.1158/1078-0432.CCR-12-1952. Epub 2012 Aug 21.
9
U.S. Food and Drug Administration approval: crizotinib for treatment of advanced or metastatic non-small cell lung cancer that is anaplastic lymphoma kinase positive.美国食品和药物管理局批准：克唑替尼治疗间变性淋巴瘤激酶阳性的晚期或转移性非小细胞肺癌。
Clin Cancer Res. 2014 Apr 15;20(8):2029-34. doi: 10.1158/1078-0432.CCR-13-3077. Epub 2014 Feb 26.
10
Successful crizotinib rechallenge after crizotinib-induced interstitial lung disease in patients with advanced non-small-cell lung cancer.晚期非小细胞肺癌患者克唑替尼诱发间质性肺病后再次成功使用克唑替尼治疗
Clin Lung Cancer. 2014 May;15(3):e33-5. doi: 10.1016/j.cllc.2013.12.004. Epub 2013 Dec 27.

引用本文的文献

1
[Lung Squamous Cell Carcinoma with EML4-ALK Fusion and TP53 Co-mutation 
Treated with Ensartinib: A Case Report and Literature Review].[恩沙替尼治疗伴有EML4-ALK融合及TP53共突变的肺鳞状细胞癌：1例报告及文献复习]
Zhongguo Fei Ai Za Zhi. 2023 Jan 20;26(1):78-82. doi: 10.3779/j.issn.1009-3419.2023.106.03.
2
Efficacy and Drug Resistance Analysis of ALK Inhibitors in Combination with Stereotactic Body Radiation Therapy for Treating Lung Squamous Carcinoma Patient Harboring EML4-ALK Rearrangement.ALK抑制剂联合立体定向体部放射治疗对携带EML4-ALK重排的肺鳞癌患者的疗效及耐药性分析
Onco Targets Ther. 2021 Dec 3;14:5385-5389. doi: 10.2147/OTT.S335736. eCollection 2021.
3
Crizotinib-induced osteitis mimicking bone metastasis in a stage IV ALK-rearranged NSCLC patient: a case report.
克唑替尼诱导的骨炎模拟 IV 期 ALK 重排 NSCLC 患者的骨转移：一例报告。
BMC Cancer. 2020 Jan 6;20(1):14. doi: 10.1186/s12885-019-6486-3.
4
Crioztinib-associated corrosive esophagitis in a bedridden lung cancer patient.一名卧床肺癌患者出现的克唑替尼相关性腐蚀性食管炎。
Kaohsiung J Med Sci. 2019 Aug;35(8):515-516. doi: 10.1002/kjm2.12068. Epub 2019 Apr 16.
5
Severe Erosive Pill Esophagitis Induced by Crizotinib Therapy: A Case Report and Literature Review.克唑替尼治疗引起的严重糜烂性药物性食管炎：一例报告及文献综述
Case Rep Gastrointest Med. 2016;2016:3562820. doi: 10.1155/2016/3562820. Epub 2016 Dec 8.
6
Severe Ulcerative Esophagitis Induced by Crizotinib Therapy.克唑替尼治疗引起的严重溃疡性食管炎。
ACG Case Rep J. 2014 Jan 10;1(2):82-4. doi: 10.14309/crj.2014.8. eCollection 2014 Jan.
7
Managing treatment-related adverse events associated with Alk inhibitors.管理与 Alk 抑制剂相关的治疗相关不良反应。
Curr Oncol. 2014 Feb;21(1):19-26. doi: 10.3747/co.21.1740.